Glutamine promotes the generation of B10 + cells via the mTOR/GSK3 pathway
Alterations in cell metabolism can shift the differentiation of immune cells toward a regulatory or inflammatory phenotype, thus, opening up new therapeutic opportunities for immune‐related diseases. Indeed, growing knowledge on T‐ cell metabolism has revealed differences in the metabolic programs of suppressive Tregs as compared to inflammatory Th1 and Th17 cells. In addition to Tregs, IL‐10‐producing regulatory B cells are crucial for maintaining tolerance, inhibiting inflammation, and autoimmunity. Yet, the metabolic networks regulating diverse B‐lymphocyte responses are not well known. Here, we show that glutaminase blockade decreased downstream mTOR activation and attenuated IL‐10 secretion. Direct suppression of mTOR activity by rapamycin selectively impaired IL‐10 production by B cells whereas secretion was restored upon Glycogen synthase kinase 3 (GSK3) inhibition. Mechanistically, we found mTORC1 activation leads to GSK3 inhibition, identifying a key signalling pathway regulating IL‐10 secretion by B lymphocytes. Thus, our results identify glutaminolysis and the mTOR/GSK3 signalling axis, as critical regulators of the generation of IL‐10 producing B cells with regulatory functions.
No keywords indexed for this article. Browse by subject →
Elizabeth C. Rosser, Claudia Mauri
Andrew N. Macintyre, Valerie A. Gerriets, Amanda G. Nichols et al.
Showing 50 of 74 references
- Published
- Feb 01, 2022
- Vol/Issue
- 52(3)
- Pages
- 418-430
- License
- View
You May Also Like
Andrea Cossarizza, Hyun‐Dong Chang · 2019
911 citations
Jasper de Boer, Adam Williams · 2003
699 citations
Mònica Comalada, Desirée Camuesco · 2005
537 citations
Manuel Modolell, Ines M. Corraliza · 1995
432 citations
Kambis Sadeghi, Barbara Wessner · 2006
408 citations